Mohammad Reza Fazlollahi Selected Research

Mohammad Reza Fazlollahi Research Topics

Disease

10	Asthma (Bronchial Asthma) 09/2021 - 01/2013
8	Hypersensitivity (Allergy) 10/2022 - 03/2013
6	Chronic Granulomatous Disease 04/2022 - 10/2011
4	Reinfection 06/2020 - 12/2012
3	Hereditary Angioedemas 01/2022 - 07/2015
3	Bacterial Infections (Bacterial Infection) 06/2020 - 06/2014
3	Scrapie 02/2018 - 04/2016
3	Primary Immunodeficiency Diseases 10/2016 - 12/2012
2	Purine Nucleoside Phosphorylase Deficiency 12/2023 - 08/2021
2	Eosinophilia 06/2022 - 01/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2022 - 04/2014
2	Wiskott-Aldrich Syndrome 08/2021 - 12/2012
2	Allergic Rhinitis 04/2018 - 11/2017
2	Eczema 01/2016 - 12/2012
1	COVID-19 10/2023
1	Infections 05/2023
1	Job Syndrome (Hyper-IgE Syndrome) 08/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2021
1	Common Variable Immunodeficiency 08/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Chronic Urticaria 01/2021
1	Bruton type agammaglobulinemia 06/2020
1	Angioedema 09/2019
1	Rheumatoid Arthritis 08/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2019
1	Autoimmune Diseases (Autoimmune Disease) 08/2019
1	Sarcoidosis (Schaumann Disease) 08/2019
1	Conjunctivitis 04/2018
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2018
1	Drug Hypersensitivity (Drug Allergy) 01/2017
1	Anaphylaxis (Anaphylactic Shock) 04/2016
1	Milk Hypersensitivity (Milk Allergy) 04/2016
1	Edema (Dropsy) 07/2015
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 04/2014
1	Griscelli syndrome type 2 08/2013
1	Thrombocytopenia (Thrombopenia) 12/2012
1	Neutropenia 03/2012

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin E (IgE)IBA 06/2022 - 01/2013
6	AllergensIBA 10/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2012
4	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2016 - 10/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021 - 02/2018
2	Purine-Nucleoside PhosphorylaseIBA 12/2023 - 08/2021
2	fludarabineIBA 04/2022 - 04/2014
2	Methylprednisolone FDA LinkGeneric 04/2022 - 04/2014
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2022 - 04/2014
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 07/2015
2	vilanterolIBA 01/2020 - 02/2018
2	fluticasone furoate FDA Link 01/2020 - 02/2018
2	VaccinesIBA 01/2019 - 01/2018
2	SmokeIBA 02/2018 - 11/2017
2	NADP (NADPH)IBA 10/2016 - 12/2012
1	Complement System Proteins (Complement)IBA 10/2023
1	SilverIBA 05/2023
1	Melphalan (Alkeran)FDA LinkGeneric 04/2022
1	Recombinases (Recombinase)IBA 08/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	MicroRNAs (MicroRNA)IBA 04/2021
1	Immunoglobulin IsotypesIBA 06/2020
1	Immunoglobulins (Immunoglobulin)IBA 06/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 06/2020
1	Bradykinin Receptor AntagonistsIBA 09/2019
1	CatalaseIBA 08/2019
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 10/2018
1	Immunoglobulin M (IgM)IBA 10/2018
1	Immunoglobulin G (IgG)IBA 10/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2018
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2017
1	Penicillins (Penicillin)FDA Link 01/2017
1	beta-LactamsIBA 01/2017
1	Caseins (Casein)FDA Link 04/2016
1	Lactalbumin (alpha-Lactalbumin)IBA 04/2016
1	Lactoglobulins (beta-Lactoglobulin)FDA Link 04/2016
1	DNA (Deoxyribonucleic Acid)IBA 03/2013
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 01/2013
1	neutrophil cytosol factor 67KIBA 12/2012
1	EnzymesIBA 12/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2012

Therapy/Procedure

4	Immunotherapy 10/2022 - 01/2018
3	Hematopoietic Stem Cell Transplantation 12/2023 - 08/2013
2	Therapeutics 01/2020 - 02/2018
1	Length of Stay 09/2019